Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for reducing side effects from administration of phosphodiesterase-4 inhibitors

Method for reducing side effects from administration of phosphodiesterase-4 inhibitors

US Patent 12042487 · Granted Jul 23, 2024

Estimated economic value: $13,093,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compositions of spironolactone for deep dermal drug delivery2025
Topical roflumilast aerosol foams2025
Method for reducing side effects from administration of phosphodiesterase-4 inhi2025
Inhibition of crystal growth of roflumilast2025
Topical roflumilast formulation having antifungal properties2025
Topical roflumilast formulation having improved delivery and plasma half-life2025
Inhibition of crystal growth of roflumilast2025
Roflumilast formulations with an improved pharmacokinetic profile2025
Pharmaceutical compositions of roflumilast and solvents capable of dissolving hi2024
Laureth-4 containing topical formulations2024
Compositions and methods for deep dermal drug delivery2024
Method and formulation for improving roflumilast skin penetration lag time2024